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1. Introduction
Progress of tissue engineering is being leveraged to advance 
several other interface biomedical fields and applications. One 
example is the development of in vitro 3D tissue and disease 
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The creation of microphysiological systems like tissue and organ-on-chip for 
in vitro modeling of human physiology and diseases is gathering increasing 
interest. However, the platforms used to build these systems have limitations 
concerning implementation, automation, and cost-effectiveness. Moreover, 
their typical plastic-based housing materials are poor recreations of native 
tissue extracellular matrix (ECM) and barriers. Here, the controlled self-
assembly of plant-derived cellulose nanocrystals (CNC) is combined with the 
concept of 3D bioprinting in suspension baths for the direct biofabrication of 
microphysiological systems embedded within an ECM mimetic fibrillar sup-
port material. The developed support CNC fluid gel allows exceptionally high-
resolution bioprinting of 3D constructs with arbitrary geometries and low 
restrictions of bioink choice. The further induction of CNC self-assembly with 
biocompatible calcium ions results in a transparent biomimetic nanoscaled 
fibrillar matrix that allows hosting different compartmentalized cell types and 
perfusable channels, has tailored permeability for biomacromolecules diffu-
sion and cellular crosstalk, and holds structural stability to support long-term 
in vitro cell maturation. In summary, this xeno-free nanoscale CNC fibrillar 
matrix allows the biofabrication of hierarchical living constructs, opening 
new opportunities not only for developing physiologically relevant 3D in vitro 
models but also for a wide range of applications in regenerative medicine.
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models with the improved potential to 
simulate native tissue/organ behavior, 
when compared to 2D cell monolayer 
cultures or even animal models, yielding 
drug responses with higher similarity to 
those of human tissues.[1] Organ/tissue-
on-chip (OoC) technology, in particular, 
has seen increasing interest in the devel-
opment of microphysiological systems 
with improved predictive power for their 
in vitro–in vivo extrapolations.[2] Although 
still in its infancy, this technology is 
developing rapidly in order to meet the 
increasing demands for reducing animal 
testing in basic research as well as in drug 
development processes.[3,4] However, the 
complexities of organ functions are diffi-
cult to model in these systems. Many dif-
ferent fabrication approaches have been 
devised in terms of model complexity and 
device designs.[3] Among the most suc-
cessful platforms currently translated into 
commercial products are those known as 
tissue plates, consisting of arrays of tissue 
chips for on-plate replicates.[5] Similar 
to the majority of other OoC platforms, 
these plates are based on predefined 
sample housing circuits made of transparent polymeric mate-
rials such as poly(methyl methacrylate) or polydimethylsiloxane 
(PDMS).[6,7] Despite mitigating the issue of sample replicate 
throughput, such platforms tend to sacrifice the potential to rec-
reate the cell–cell and cell–extracellular matrix (ECM) cross-talk 
existing in living organisms. In vivo, parenchyma and its cor-
responding stromal tissues are primarily made of non-cellular 
interstitial fibrillar ECM that support the function of the cel-
lular constituents.[8] Cells and ECM are hierarchically organized 
by basement membranes (BM) that divide them into compart-
ments.[9] Structurally, this specialized form of ECM consists of 
dense 3D fibrillar networks that, despite having a tissue-specific 
composition, conserve their nanoscale topographical features 
across anatomical locations.[10,11] Beyond the signaling derived 
from the biochemical nature of their components, the biophys-
ical cues stemming from the nanoscale supramolecular organi-
zation of ECM and BM have a far more important biological 
function than simply providing structural support for cells.[9,12] 
These fibrillar architectures of ECMs convey mechanical and 
topological signals that have many recognized roles in the regu-
lation of important cellular mechanisms such as migration, 
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mechanotransduction, or morphogenesis.[8,12] In addition to 
biophysical cues, the permeability allowed by the interstitial 
space of fibrous ECMs is also crucial for regulating cell sign-
aling because it controls the permeation and mass transport of 
bioactive macromolecules, nutrients, and wastes.[13]
Although numerous pathophysiological findings have 
derived from OoC models housed in the typical plastic plat-
forms commonly used for microfluidic device fabrication, their 
inability to recreate the 3D fibrillar nature of the compartmen-
talization barriers and the interstitial spaces where biological 
processes occur is a major limitation of these systems.[14] 
Moreover, tissues and organs have 3D structures with architec-
tures on different length scales crucial for their complex bio-
logical function,[15] which are difficult to reproduce on current 
OoC platforms usually based on circuits with fixed predefined 
geometries.[16] Additionally, many conventional microfluidic 
devices often require cumbersome microfabrication manu-
facturing processes[17,18] and complicated cell and biomaterial 
handling procedures that have not yet proven to be sufficiently 
efficient, feasible, or economical.[19] Therefore, combinations of 
fabrication strategies and biomaterial platforms enabling the 
automated manufacture of 3D cellular constructions while pro-
viding the intrinsic barrier function of fibrillar ECMs and BMs 
would be a major advance in the field. By allowing the creation 
of OoC systems with more biomimetic cell–cell and cell–matrix 
crosstalk, such a platform would contribute to the construction 
of complex compartmentalized 3D tissue models with higher 
physiological relevance.
Self-assembling materials, of either natural or synthetic 
origin, offer unique advantages to provide a rich landscape of 
ECM-mimetic nanoscale filamentous structures, networks, and 
pores.[16] If rationally integrated with biofabrication technologies 
such as 3D bioprinting,[1,20] these man-made supramolecular 
hydrogels can be leveraged for the bottom-up assembly of com-
plex 3D structures with well-defined nano-to-macroscale hierar-
chical architectures. A few recent studies have started to explore 
this biofabrication approach. For example, fibrillar bioinks 
based on ultrashort peptide self-assembly were applied to print 
stable large-scale constructs with high shape fidelity, enabling 
long-term cell survival and robust chondrogenic differentiation 
of mesenchymal stem cells.[21] The Mata research group has 
been exploring the interfacial coassembly between elastin-like 
recombinamer and graphene oxide for the liquid-in-liquid bio-
printing of perfusable fluidic devices with nanostructured wall 
membranes showing tunable anisotropic permeability.[22,23]
Building on these concepts, here we propose an innovative 
bottom-up strategy for the direct manufacture of cell-laden 
devices that recreate the unique biophysical cues from the native 
fibrillar ECMs while allowing the design of embedded bioen-
gineered constructs with arbitrary geometries. The proposed 
platform combines the concepts of 3D free-form bioprinting in 
suspension media[24] with the controlled self-assembly of plant-
derived cellulose nanocrystals (CNC)[8,25] as building blocks to 
fabricate cell-laden constructs embedded within its own fibrillar 
hydrogel device (Figure  1). An inherent requirement of the 
proposed hypothesis is that hydrogel formation has to occur 
around cells and therefore fiber assembly and gelation mech-
anisms have to be cytocompatible. The ability to regulate the 
rheological behavior of CNC colloidal suspensions and induce 
their ion-mediated self-assembly by nanoparticle surface charge 
screening with biocompatible ions[26] suggests that it might 
be a well-suited option for the implementation of this fabrica-
tion strategy. However, fine control over such mechanisms, 
not only to produce a fluid gel with the required rheological 
Figure 1. The print-then-lock concept for the fabrication of bioprinted microphysiological systems embedded within a bioinspired hierarchical fibrillar 
matrix. A) Colloidal suspensions of CNC with defined rheology are used as support fluid gels to fabricate 3D constructs with arbitrary geometries. B) The 
printed constructs are then locked within a fibrillar matrix by inducing CNC self-assembly with the addition of calcium ions. C) Bioprinted constructs 
embedded within the fibrillar matrix are cultured for in vitro maturation and bioassays. This platform enables possible application as: D) housing sup-
port materials for tissue and organ-on-chip microfluidic device; E) on-plate 3D bioprinted models for medium- to high-throughput assay replicates; 
F) temporary templating bioreactors for in vitro maturation of 3D bioprinted tissue constructs that can be harvested after CNC matrix bioorthogonal 
digestion.
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behavior to assist on the bioprinting process[24] but also to lock 
the resulting structures within a stable fibrillar matrix after 
printing, need to be optimized. A few examples of granular 
microgels[27,28] or shear-thinning macromolecular hydrogels 
systems based on specific chemical modifications for reversible 
crosslinking[29] have been proposed as support materials for the 
direct writing and long term maturation of embedded 3D cel-
lular constructs, as well as to support the bioassembly of cell 
spheroids.[30] Although these systems could be considered as 
alternatives to implementing the concept proposed here, they 
do not recapitulate the filamentous nature of the ECM, among 
other comparative disadvantages to CNC-based fibrillar matrix 
in terms of synthesis complexity and cost of implementation. 
On the other hand, fibrillar proteins, such as fibrin or collagen, 
could be considered as an alternative to CNC to implement this 
strategy. However, although it has been shown that fibrin gels 
could retain cell spheroids in defined positions of the 3D space 
placed by a custom-made printing system and then assist on 
their bioassembly during culture,[31] fibrin and collagen gels do 
not show the required shear-thinning and self-healing behavior 
to be used as support baths for the bioprinting of complex 3D 
structures using the traditional extrusion-based systems. More-
over, unlike CNC that are low cost xeno-free materials, these 
proteins are usually obtained from animal origins, result in soft 
gels with low capacity to retain the original shape of 3D printed 
structures and undergo cell-mediated retraction, suffering 
as well of fast proteolytic degradation during in vitro cell cul-
ture.[32,33] These characteristics limit their potential to be used 
as housing material for dynamic in vitro modeling, particularly 
if medium to long-term cell culture is aimed.
To test the versatility of the proposed platform, here we pro-
duced CNC fluid gels with optimized rheological properties 
meeting the demands for 3D bioprinting in suspension media 
and controlled its further self-assembly into fibrillary hydrogel 
devices after printing the desired complex 3D structures. The 
combination of these hierarchical support material and fabrica-
tion technology for creating microfluidic channels and multi-
cellular 3D constructs embedded within a biomimetic fibrillar 
matrix is demonstrated, facilitating the rapid generation of large 
numbers of microphysiological systems that can be leveraged 
for in vitro modeling in different assay formats. The implemen-
tation of the proposed concept is tested with various cell types 
and bioinks, and their biological performance is evaluated in 
both static and dynamic conditions. The range of comparative 
advantages offered by this system further provides a potential 
solution to scale-up for bioengineered tissue manufacture.
2. Results and Discussion
2.1. Self-Assembled CNC Fibrillar Hydrogels as Support Matrix 
to “print-then-lock” Embedded Structures
A key requirement to enable the printing of high-resolution 
constructions applying the strategy of 3D bioprinting in suspen-
sion media is the use of support baths with adequate rheolog-
ical behavior capable of providing a semisolid medium to print 
into.[24] CNC colloidal stability in aqueous media depends on its 
synthesis method but is often based on electrostatic repulsions 
provided by surface-charged groups.[25,34] On the other hand, 
due to their abundant surface hydroxyl groups, CNC can estab-
lish extensive hydrogen bonding and form shear-thinning 
physical gels at high nanoparticle concentration (usually above 
≈7 wt%),[35] suggesting that it can potentially be used as a fluid 
gel to assist bioprinting processes. Interestingly, shielding of 
CNC surface charges with mono or bivalent biocompatible ions 
(e.g., Na+ or Ca2+) has been applied not only to control the rheo-
logical behavior of these colloidal suspensions and produce vis-
cous gels at much lower nanoparticle concentration (lower limit 
of about 1 wt%) but also to induce the further self-assembly of 
these building-blocks into bioinspired fibrillar hydrogels with 
high structural cohesion and optical transparency.[26,36] These 
intrinsic properties of CNC suspensions are thus fundamental 
for the concept here proposed because they can be explored to 
produce fluid gels as support baths for high-resolution printing 
of complex compartmentalized 3D freeform structures, as well 
as for its further embedding within a biomimetic ECM fibrillar 
matrix under straightforward biocompatible conditions, a con-
cept that we term as “print-then-lock” approach.
To prove this, CNC were produced from microcrystalline 
cellulose by sulfuric acid hydrolysis, a method that leads to 
negatively charged nanoparticles grafted with sulfate groups on 
their surface.[37] Their morphological characterization by scan 
transmission electron microscopy (STEM) showed rod-shaped 
nanocrystals with the dimension of 173.4 ± 16.1 nm in length 
and 4.9 ± 1.8 nm in width (Figure  2B), consistent with our 
previous studies.[38,39] The viscoelastic behavior of CNC suspen-
sions as a function of nanoparticle and calcium ions concentra-
tion was then characterized. To establish the window of CNC 
versus ionic strength that leads to fluid gels displaying suitable 
behavior to assist the printing process, we first performed a 
qualitative evaluation by a simple inversion test (Figure S1 Sup-
porting Information). The range of tested CNC and Ca2+ con-
centrations was selected to vary around the reported threshold 
values for CNC sol–gel transition by addition of this ion,[27] 
which are situated at ≈1.5 wt% and ≈2.0 × 10-3 m, respec-
tively. Results show that the viscosity of CNC suspensions has 
a mutual nanoparticle—ionic strength dependence: they start 
to become viscous enough to resist gravity-driven flow at CNC 
concentrations of 1.5 wt% with the addition of 2.5 × 10-3 m of 
Ca2+ and resulted in viscous gels that did not flow (within the 
time frame of the test) at 2.5 wt% CNC and 2 × 10-3 m Ca2+. 
To evaluate if these gels could be applied as support media to 
assist in the embedded bioprinting process, preliminary print-
ability tests were performed using a 10 wt% gelatin ink. As 
seen in Figure S2A in the Supporting Information, the lower 
limit of parameters that ensured printability is 2 wt% CNC and 
1.5 × 10-3 m Ca2+. While keeping the CNC concentration con-
stant at 2.5 wt% and varying the ionic strength of the suspen-
sion (1.5–7.5 × 10-3 m Ca2+), 2 × 10-3 m Ca2+ fluid gel showed the 
best performance in retaining the printed structure’s shape and 
fidelity (grid pattern, 20% infill, 27G needle as a nozzle) without 
leaving noticeable crevices and raised peaks in the CNC support 
matrix originated by the movement of the nozzle, which in con-
trast could be well noticed in the 7.5 × 10-3 m Ca2+ formulation. 
Rheology tests were then performed to further assess the impact 
of ionic strength on the viscoelastic behavior of CNC suspen-
sions and confirmed that they exhibit the required properties 
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Figure 2. A) Schematic illustration of the transition of a colloidal suspension of CNC into a fluid gel by partial surface charge screening on the addition 
of Ca2+ ions followed by its locking into fibrillar matrix by CNC self-assembly induced by the addition of excess cations. Scanning electron microscopy 
images (SEM) of B) CNC showing its rod-shaped morphology, and C) self-assembled hydrogel showing hierarchical arrangements of CNC into fibrillar 
networks (scale bar: 200 nm). D) Shear viscosity of the 2.5 wt% CNC suspensions at variable concentration of Ca2+ ions: 0 × 10-3 m (green), 2.5 × 10-3 m 
(pink) and 7.5 × 10-3 m (blue). E) Evaluation of self-healing properties CNC hydrogel by subjecting the 2.5 wt% CNC with 2 × 10-3 m Ca2+ (pink) or 
7.5 × 10-3 m Ca2+ (blue) to alternating high (200%) and low (1%) strain cycles (G′: storage modulus, solid symbols, G″: loss modulus, hollow symbols). 
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to be used as a support media for embedded bioprinting. The 
shear rate dependence of viscosity of 2.5 wt% CNC suspensions 
at different electrolyte concentrations are shown in Figure  2C 
and its corresponding strain sweeps are shown in Figure S2B 
(Supporting Information). In agreement with the results of the 
qualitative assays, increasing Ca2+ gradually increased the vis-
cosity of the CNC suspensions as a result of nanoparticle sur-
face charge screening, which compresses the thickness of the 
electrical double layer and promotes their lateral aggregation.[40] 
During this process, CNC established enough network perco-
lation,[26] transitioning from low viscosity liquids to solid-like 
hydrogels of increasing storage moduli following the increase 
of suspension’s ionic strength (Figure 2A). These results are in 
good agreement with previous studies where the dependence 
of CNC hydrogel stiffness on ionic strength has been demon-
strated, a phenomenon attributed to enhanced side-by-side 
self-assembly of CNC promoted by the effects of cations addi-
tion.[26,41] Mechanistically, the addition of Ca2+ ions reduces the 
Debye length of nanoparticles that consequently leads to their 
lateral aggregation driven by dominant attractive interactions 
(e.g., van der Waals forces and hydrogen bonding) mainly estab-
lished by the abundant hydroxyl groups on their surface. When 
CNC fluid gels were locked with an excess of Ca2+ (7.5 × 10-3 m), 
it resulted in stable hydrogels with a well-developed hierarchical 
fibrillar architecture, as shown in Figure 2C. Interestingly, it has 
been previously suggested that divalent cations whose metal 
sulfates have low solubility in water such as the Ca2+ used here, 
can more effectively bridge two sulfate groups of adjacent CNC, 
imparting an interparticle crosslink effect to the system that 
leads to more stable and rigid hydrogels that those produced 
with Mg2+ or monovalent ions such as Na+.[27] Remarkably, 
this man-made biomimetic matrix was composed of entangled 
fibrils with a mean diameter of 28.5 ± 11.3 nm and mean pore 
size of 76.7 ± 17.8 nm (Figure S2F,G, Supporting Information), 
falling within the corresponding range of dimensions found in 
native ECMs.[8,10,11] In vivo, the ECM fibrils of parenchyma and 
stromal tissues varied from 10 nm to 230 nm, depending on the 
tissue type,[8] while the dense 3D networks of BM had a pore 
size ranging from about 10 to 130 nm.[10,11]
Of particular interest for the proposed application was the 
CNC fluid gel shear-thinning (Figure  2D) and stress-yielding 
(Figure  2E) responses, reflecting the shear-induced disruption 
of the non-covalent nanoparticle assemblies formed by the addi-
tion of Ca2+. Moreover, after disruption by an external mechan-
ical stimulus, CNC hydrogels were able to rapidly recover 
from a predominantly viscous to a predominantly elastic state 
(Figure  2E), demonstrating self-healing potential.[42] Interest-
ingly, similar self-healing behavior has also been observed in 
CNC hydrogels produced by hydrothermal desulfation of their 
surface.[43] This suggests that the multiple non-covalent interac-
tions established between the high surface area and aspect ratio 
CNC, including not only van der Waals and hydrogen bonding 
but likely, also ionic bridging mediated by Ca2+, are main 
contributors for the observed self-healing behavior of CNC 
fluid gels. This characteristic is essential as support media in 
order to hold in place the extruded ink behind the nozzle after 
printing and prevent crevice formation.[44] The tunable rheology 
of CNC suspensions mediated by Ca2+ ions confers to this 
material excellent properties as a support media for printing 
with different inks, including liquid build constructions based 
on different post-printing solidification approaches.[44] In fact, 
3D printing with liquid and low viscosity inks is still the main 
challenge in extrusion-based bioprinting, limiting the options 
of biomaterials and crosslinking mechanisms that can be used 
with these technologies.[45,46] To illustrate the freedom of bio-
material choice allowed by our CNC-based fluid gel we printed 
various low viscosity inks based on hydrogel precursors with 
different crosslinking mechanisms (Figure  2F): 5 wt% gelatin 
crosslinked by microbial transglutaminase (mTG)[37,47] diffusing 
from CNC fluid gel as representative of enzymatic crosslinking 
(GelTG), 2 wt% alginate as representative of ionic crosslinking, 
and 5 wt% methacrylated gelatin (GelMA) as representative of 
photo-crosslinking. Based on the results of the rheological char-
acterization, 2.5 wt% CNC suspensions with 2 × 10-3 m Ca2+ 
were selected as support fluid gel to assist the printing process 
and a 7.5 × 10-3 m Ca2+ solution was used to induce the post-
printing self-assembly of CNC, embedding the printed struc-
tures within the fibrillary matrix according to the proposed 
“print-then-lock” concept. As shown in Figure  2F, the resolu-
tion and fidelity of the printed patterns were well maintained, 
irrespective of the nature of the ink polymer or its crosslinking 
mechanism. This versatility is not only particularly interesting 
for the proposed concept, but also for the field of embedded 
bioprinting in general as it confers low restriction on the type of 
ink material that can be explored for each particular application.
Besides the advantages of versatility in ink choice, the CNC 
fluid gel also provided improved printing fidelity and resolution 
compared to other microparticle-based support materials typi-
cally used in the field. To demonstrate its superior performance 
in assisting the printing process, we compared CNC with an 
agarose microparticle fluid gel that has been widely used as a 
support bath in several studies,[48,49] including our own.[50] As 
shown in Figure 2G,H, 5 wt% gelatin ink printed at the same 
speed and pressure with a 27G nozzle into these two different 
support materials result in filaments with diameters of 904.6 ± 
34.1 µm in the agarose bath (Figure 2G) and of 181.2 ± 11.3 µm 
in our CNC fluid gel (Figure 2H). Further, while the irregular 
agarose microparticles created tortuosity on the print bed path 
that leads to roughened filaments with a variable diameter[48] 
(Figure 2I), a problem shared by the other microparticle-based 
support materials,[51] no major visible distortion or particle 
footprints were seen on the surface of the filaments printed in 
F) CAD design and respective photographs of two-layered linear patterns and a continuously extruded spiral printed in CNC colloidal matrix with 5 wt% 
gelatin (GelTG, enzymatic crosslinking), 2 wt% alginate (ionic-crosslinking) and 5 wt% GelMA (photo-crosslinking) (scale bar: 500 µm). Confocal 
images comparing the resolution of fluorescently labeled (FITC) gelatin ink printed within G) 0.5 wt% agarose slurry and H) 2.5 wt% CNC colloidal 
suspension (scale bar: 250 µm). Photographs of lattice structures with 10 × 10 × 1 mm and 20% rectilinear infill printed in I) 0.5 wt% agarose slurry 
and J) 2.5 wt% CNC colloidal suspension (scale bar:1 mm). Photographs showing the optical transparency of K) agarose bath, and L) CNC colloidal 
suspension. M) Resolution of FITC-labeled gelatin 5 wt% ink printed at a constant pressure of 5 kPa and variable speed of 3, 5, and 8 mm s-1 with a 
30G nozzle (scale bar: 150 µm). Images are representative of n  =  3 independent experiments, data are means ± SD.
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our colloidal CNC fluid gel (Figure  2J). Due to the rapid self-
healing behavior of this support material, the filament resolu-
tion could be easily tuned by varying the printing speed without 
negatively affecting the dispersion and distribution of the ink, 
ranging from 172 ± 4.2 µm at 3 mm s-1 down to 37 ± 5.1 µm 
at 8 mm s-1 (Figure  2M, Figure S3A,B Supporting Informa-
tion). Similarly, unlike microparticulate baths[48,51] that are 
typically translucent but not completely transparent compro-
mising its macro and microscopic post-printing optical analysis 
(Figure 2K, Figure S3C, Supporting Information), our fibrillar 
CNC matrix is highly transparent (Figure 2L, Figure S3D, Sup-
porting Information).
Next, we tested the capability of the CNC fibrillar matrix to 
withhold perfusable channels, an integral feature of micro-
physiological systems built on microfluidic OoC platforms.[52] 
The thermoresponsive polymer Pluronic F-127 was used 
as fugitive ink to create an open channel (Figure  3A). After 
printing the desired structures (Figure  3B) and locking the 
CNC with calcium ions (Figure 3C), the perfusability of the cre-
ated channels was demonstrated by injection of colored dye 
solutions (Figure  3D, Movie S2, Supporting Information). To 
show that perfusable microchannels can be easily fabricated in 
our “print-then-lock” system irrespective of their design com-
plexity, we printed a series of structures with different arbitrary 
patterns: a common microfluidics chip design with bifurcated 
channels (Figure 3E), a design with three different inlets and a 
convergence point in the middle (Figure 3F), and multilayered 
channels (Figure  3G). The capacity for automated fabrication 
of perfusable microchannel networks with structural integrity 
using this system shows that it can be considered as an alter-
native to conventional polymeric microfluidic chip platforms,[7] 
with the advantage of allowing the direct 3D writing of hetero-
geneous microphysiological systems requiring compartmentali-
zation and perfusion for in vitro tissue/organ and disease mod-
eling. Furthermore, these fabrication steps can be performed 
under biocompatible conditions, an aspect that has several 
advantages over competing technologies, beyond the inherent 
benefits derived from its potential to emulate the physical cues 
of the ECM fibrillar structure. For instance, compared to other 
nanocellulose-based paper devices fabricated applying similar 
matrix-assisted 3D printing concepts, it avoids the need for 
post-printing construct drying to confer structural cohesion to 
the device or the need for high-temperature treatments and 
extensive organic solvent washing for the removal of hydro-
phobic sacrificial inks.[53,54] On the other hand, compared to 
PDMS-based microfluidic devices, the most popular platform 
used in the field, it bypasses the need for multiple and tedious 
microfabrication steps required for their manufacturing.[55,56] 
Moreover, CNC are derived from renewable plant-based sources 
providing a green chemistry and sustainable alternative to 
existing plastic polymers widely in use for fabricating microflu-
idic devices.[57]
A fundamental requirement for developing functional in 
vitro tissue models is ensuring the availability of oxygen, nutri-
ents, and signaling molecules to support cell activities. Thus, 
controlling their diffusion and permeability through cellular 
constructs is a key factor to be addressed while developing 
these systems.[58] As discussed above, BM and ECM play crit-
ical roles in the regulation of this mass transport phenomena, 
which are essential for cell function but are poorly recreated 
by the solid polymeric materials and microporous membranes 
used as barriers for cellular compartmentalization in micro-
fluidic devices.[3] The fibrillar nature of the CNC matrix sug-
gests that it can better mimic the interstitial permeability of 
the ECM for biomolecule diffusion, contributing to improving 
the biological relevance of the fabricated microphysiological 
systems in comparison with polymeric barriers used on OoC 
devices. To demonstrate the permeability of the CNC matrix 
for biomolecules of different sizes, we evaluated the diffusion 
of FITC-labeled dextrans (4 kDa and 250 kDa, used as model 
biomolecules) through the fibrillar network from a sacrificially 
printed 200 µm microchannel over the time course of 60 min. 
Although the low molecular weight dextran (Figure 3H–J) logi-
cally diffuses faster than the corresponding high molecular 
weight (Figure  3K–M), the interstitial porosity of the CNC 
matrix (Figure S4, Supporting Information) allows an easy 
but controlled spatiotemporal diffusion of biomolecules, cre-
ating concentration gradients through the hydrogel volume. 
This permeability is in different aspects remarkable for sup-
port and barrier materials of microphysiological systems. First, 
it ensures that the compartmentalized 3D cellular constructs 
embedded in the matrix will receive the nutrients they need to 
survive while allowing cellular signaling crosstalk during the in 
vitro maturation and functional assessment steps. Second, by 
generating concentration gradients of biomolecules, which play 
key roles in the regulation of a wide range of biological pro-
cesses including, e.g., development, wound healing, or cancer 
metastasis,[59] it will improve the biological significance of the 
proposed models compared with the typical mass transport 
occurring through perforated membranes used in microfluidic 
OoC devices.
On the other hand, the 3D shape and architecture of cellular 
constructions are known to significantly affect the functional 
outcome of bioengineered tissue/organ in vitro models.[60,61] 
Therefore, the ability to precisely recreate the specific 3D archi-
tectural hallmarks of each tissue contributes to increasing the 
predictive power of these bioengineered systems.[3] The con-
cept of bioprinting complex heterogeneous models embedded 
within its own support bioreactor is largely dependent on 
the properties of the fluid support media. The overall goal of 
the strategy is to achieve multi-component and multilayered 
structures without dispersion of extruded bioinks while main-
taining the structural fidelity of the construct. Applications of 
3D printing in support media have used different granular,[49,62] 
microparticle[48,51,63,64] or even liquid solution[65] as fluid sup-
porting material. Despite the significant advances, a compro-
mise between either shape fidelity and resolution or biocompat-
ibility and biomimicry along with, in some cases, the need for 
extensive processing[53] have been often required. To demon-
strate the capability of our CNC fluid gel to support the easy fab-
rication of delicate freeform structures using low viscosity inks, 
we printed a 15 mm high multicomponent coil using GelTG 
and multiple printheads.[49] As shown in Figure 3N–O, the CNC 
matrix allowed high-resolution printing of the coil, without 
noticeable distortions caused by the repeated movements of 
the nozzle in 3D space during the printing process. Moreover, 
our system also enables the relatively fast fabrication of dense 
volumetric structures with excellent resolution and precision, 
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as demonstrated by the printing of a miniaturized right human 
kidney (5 mm height, 25 layers, and 65% infill, printing time = 
7 min, Figure  3P,Q). Note that extrusion-based bioprinting is 
slower than other emerging stereolithography-based methods 
for bioprinting of complex structures, although currently they 
still possess lower potential for multicellular construction.[66,67]
Interestingly, nanocelluloses are biocompatible materials 
that are not biodegradable in mammalian organisms but can be 
bioorthogonally degraded by cellulase enzymes (the resulting 
by-product being just glucose).[25,68] Thus, the CNC matrix 
can be used as a template bioreactor for the in vitro matura-
tion of complex bioprinted constructs and then allow their 
mild release by enzymatic digestion of the support material for 
downstream in vitro biological analysis or even for its poten-
tial in vivo transplantation. To demonstrate this, we printed a 
complex 3D butterfly of 15 mm height, 12 mm width, and vari-
able wing thickness ranging from 1.5 mm at the bottom down 
to 0.5 mm on top with GelTG ink (CAD design in Figure 3R, 
Movie S1, Supporting Information). After printing, the struc-
ture was locked in the CNC matrix by addition of calcium ions 
(Figure 3S), allowed to crosslink for 30 min and then released 
from the support materials by digestion of CNC with cellu-
lase under cell culture conditions (cell culture media at 37 °C 
for 24 h).[68] Unlike mechanical aspiration of the granular and 
microparticles based slurries typically used as support baths,[69] 
a process that can jeopardize the integrity of delicate structures, 
the enzymatic release is slower but leaves no major visible resi-
dues of the support material on the released structure and the 
fidelity of the 3D printed model was well preserved (Figure 3T), 
as previously shown using enzymatic degradation of alginate 
microparticles.[63]
2.2. Manufacturing Microphysiological Systems Embedded into 
CNC Fibrillar Matrix
Next, we evaluated the performance of the CNC matrix as a 
platform for building living microphysiological systems. To 
demonstrate that it can support the bioprinting of complex 3D 
structures and their long-term in vitro maturation, we tested 
different low viscosity bioinks and used human adipose-derived 
stem cells (hASCs) as a representative source of stromal/stem 
cells widely applied on the fabrication of tissue-engineered 
constructs.[70] Although more challenging to print,[71] bioinks 
with relatively high cell densities (6 × 106 cells mL-1) were 
chosen due to the increasing evidence that cell–cell interactions 
are essential for their condensation into functional bioengi-
neered tissues[72,73] and therefore might contribute to improve 
the biological significance of fabricated systems. Two different 
hydrogel precursors were tested: gelatin (5 wt%, GelTG), a 
widely used bioink material;[71] and platelet lysate (PL), a bioac-
tive human-derived liquid formulation that, as we have recently 
demonstrated,[50] gels in the presence of calcium ions, pro-
motes fast cellular colonization and remodeling of bioprinted 
constructs, but lacks the physical properties to maintain its 
structural integrity.
Filaments showing good resolution and homogenous cell 
distribution without noticeable dispersion into the support mate-
rial were obtained with both bioinks (Figure 4A,B, Figure S5A,B, 
Supporting Information). This confirms that the CNC fluid gel 
provided the required flow restriction for the extruded solu-
tions, and its further self-assembly into a fibrillar matrix by 
Ca2+ ions locks the printed structures in space during bioink 
gelation. Moreover, the CNC matrix supported the in vitro mat-
uration of embedded 3D printed constructs, maintaining high 
cell viability (Figure 4D,E) and the original filament shape res-
olution (Figure  4C). Interestingly, although no significant dif-
ference was observed in cell density at day 1, PL-based bioink 
showed a twofold increase in cell density compared to gelatin 
at day 14 (Figure  4F), demonstrating its highly inductive cell 
proliferation properties.[33] The high cell density, viability, and 
shape fidelity are not only maintained in simple constructs with 
low infill but also in complex volumetric 3D bioprinted struc-
tures (miniaturized structure of human femur bone, 60% infill, 
Figure  4G–I). This combination of PL-based bioink and sup-
port device might therefore be an interesting fabrication option 
to reduce the time required to generate mature 3D constructs 
with organotypic cellular density, as preferred for improving 
functional in vitro modeling.[3,74]
To demonstrate that the maturated tissue can be harvested 
from the support materials on-demand after the culture steps, 
disc-shaped constructs (rectilinear pattern, 25% infill, 27G 
nozzle) were printed with GelTG, cultured within the CNC 
fibrillar matrix for 7 days, and then retrieved via enzymatic 
hydrolysis with cellulase.[68,75] As shown in Figure  4J–M, the 
densely cellularized construct kept its 3D printed shape and 
Figure 3. A) Illustration of the process for direct 3D printing perfusable channels within CNC fibrillar matrix: i) print channel circuit with fugitive ink, 
ii) lock structure inducing self-assembly of the CNC with Ca2+, (iii) perfusion of the self-standing embedded channel after purging the sacrificial ink. 
B) Photograph of a printed and locked sinusoidal filament with Pluronic F-127 fugitive ink, C) its liquefacation at 4 °C, and D) perfusion of the hollow 
channel with water (added food color for visualization). CAD models and respective perfusion of resulting microfluidic chip with E) bifurcated design, 
F) independent inlets and bifurcations with common convergence point (water with different food colors is perfused to aid the visualization of each 
channel independently), G) multilayered channels separated by a depth distance of 500 µm (water is perfused with blue food color in the bottom 
layer and red in the top layer to aid visualization, scale bars in B, C, D, E, F, G: 1 mm). Time-lapse fluorescence images of a hollow channel filled with 
dextran 4 kDa at H) 0 min and at I) 60 min postinjection. J) Plot of spatiotemporal fluorescence intensity for dextran 4 kDa throughout CNC matrix. 
Time-lapse fluorescence images of a hollow channel filled with dextran 250 kDa at K) 0 min and at L) 60 min postinjection. M) Plot of spatiotemporal 
fluorescence intensity for dextran 250 kDa throughout CNC matrix. Red and white dotted lines represent the limits of the fabricated channel and of 
detected fluorescence, respectively (scale bars in H, I, K, L: 200 µm). N) CAD model of the suspended spiral with 15 mm height, and O) respective 
embedded 3D print with multiple printheads. P) CAD model of miniaturized human right kidney, and Q) respective 3D printed structure with high 
volumetric infill (65% concentric infill pattern, 25 layers with 200 µm layer height). R) CAD model of a butterfly, and S) respective 3D printed and locked 
structure (height 15 mm and width 12 mm, wings with 1.5 mm thickness on the bottom and 0.5 mm on top). T) Released structure immersed in PBS 
after enzymatic hydrolysis of CNC matrix with cellulase. O, Q, S structures were fabricated using GelTG ink and 27G nozzle. Food colors were added 
to aid visualization, (scale bars in Q, S, T: 1 mm).
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microfilament resolution after release, demonstrating that the 
reverse templating process is stable and effective.
While different strategies for manufacturing micro-
physiological systems have been tested, yielding excellent 
results, they often have limitations of scalability or adaptability 
required for in vitro applications.[76] Most of the current complex 
tissue chip platforms are of very low throughput, allowing up to 
dozens of replicates to be performed simultaneously, in the best-
case scenarios.[5] As they improve throughput capacity, tissue 
plate platforms (arrays of tissue chips for on-plate replicates) 
are becoming popular options for in vitro modeling.[7] However, 
although addressing the question of sample replicates, these 
platforms are based on predefined sample housing circuits, sac-
rificing the flexibility and adaptation of the chip configurations 
for specific biological contexts of use. Therefore, automated bio-
fabrication platforms that contribute to facilitating the manufac-
ture of miniaturized OoC systems at higher throughputs and 
replication numbers are highly sought in the field.[77,78] Our 
CNC platform allows the rapid generation of large numbers 
of highly reproducible heterogeneous constructs with arbitrary 
Figure 4. A) 3D brightfield image reconstruction of CNC matrix embedding lattice structures printed with hASCs in PL bioinks (rectilinear pattern, 25% 
infill printed with 27G nozzle), and B) respective confocal laser microscopy (CLM) image sowing hASCs spatial distribution at day 0. C) 3D CLM image 
of hASCs cytoskeleton in PL bioinks after 4 weeks in culture. (A, B, C scale bar: 200 µm). hASCs viability (live\dead assay) in bioprinted constructs 
with D) GelTG; and E) PL hydrogel bioinks after 14 d of culture (D, E scale bar: 200 µm). F) Estimation of cell proliferation based on cell density by 
construct areas over a culture period of 14 d (ns p > 0.05, * p < 0.01, ** p < 0.001, *** p < 0.001, determined by two-way ANOVA followed by Tukey’s 
post hoc tests). G) CAD design of miniaturized human femur along with a photograph of the respective embedded bioprinted construct using hASCs 
in PL bioink after 2 weeks of culture. H) CLM projection image of live\dead assay of the biofabricated femur embedded in CNC fibrillar matrix and 
I) its cross-section cut view (H and I scale bar: 1 mm). J) CAD design of 3D disc model with 5 mm diameter and 1 mm height. K) Photograph of the 
enzymatically (cellulose) released bioprinted disc-shaped construct after 7 d in culture, and L,M) its respective CLM images of cell cytoskeleton (scale 
bar L: 1 mm, M: 100 µm). Images are representative of n  =  3 independent experiments, data are means ± SD.
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and fast and easy to redesign 3D shapes on standard cell cul-
ture multiwell plates (Figure 5A). For instance, it took less than 
5 min to print 12 replicates of a two-component squared struc-
ture with dimensions of 10 × 10 × 0.4 mm and 20% rectilinear 
infill pattern with a 27G nozzle, allowing immediate real-time 
monitoring of embedded cell patterns without compromising 
the integrity of fabricated constructs (Figure 5B). Furthermore, 
it enables the manufacturing of multicellular and multicom-
ponent 3D systems with cell compartmentalization within an 
ECM mimetic fibrillar matrix (Figure 5C), or the simulation of 
tissue interfaces typically found in most OoC platforms.[3] As 
shown in Figure 5D–F using hASCs labeled with a fluorescent 
dye and encapsulated in different bioink hydrogels (PL and 
GelTG) for demonstration, heterogeneous 3D constructs with 
different geometries and microscale precision could be easily 
printed without requiring specialized expertise for the fabrica-
tion or operation of the device. These represent comparative 
advantages over the time-consuming steps of microfabrication 
(in the order of days) and cell loading required to build micro-
physiological systems on customized PDMS-based platforms.[79]
2.3. Fabrication of Dynamic OoC Systems Enabled by  
Multimaterial Bioprinting Approaches
Besides recreating the 3D nature and arrangements of tissues 
integrating multiple cell types to reflect its physiological context, 
a key feature of OoC models are the biochemical and biophys-
ical cues deriving from the emulation of their dynamic environ-
ments. One way of adding dynamic environmental factors in 
these models is by introducing fluid flow across tissues through 
microfluidic channels or bioengineered vasculature, to deliver 
and remove cell culture media and also to remove associated 
cell metabolites and wastes.[3] In the simplest approach, tissue 
plates use gravity-driven flow to perfuse the system, eliminating 
the need for use of external pumps and maintaining the advan-
tages of well plate format.[7] Considering that the CNC platform 
allows the printing of dense volumetric structures, it should 
allow the incorporation of sacrificial reservoirs and fluid circuits 
for similar gravity-driven flow systems. However, certain appli-
cations might require a finer fluid flow control that can only be 
provided by external pumps. Therefore, we explored the poten-
tial of multimaterial biofabrication approaches to manufacture 
microphysiological systems incorporating different types of 
cells within its own microfluidic perfusion bioreactor.
We started by engineering vascular channels, a key compo-
nent of many tissue interface models. Silicone gaskets were first 
printed on a glass slide demarcating the outer border of the 3D 
tissue chip that was then filled with CNC fluid gel (Figure 6A). 
Next, instead of using fugitive inks to create open channels 
requiring subsequent cell lining, HUVEC suspended in gelatin 
was used as bioink for direct printing the vascular channel 
and simultaneously achieve its in situ endothelization.[80,81] 
After printing, the channel structure was connected to hollow 
Figure 5. A) Photograph of representative heterogeneous tissue model with the dimension of 10 × 10 × 0.4 mm and 200 µm layer height (2 layers) 
printed in a 12-well tissue culture plate (food colors were added into the ink to aid on visualization). B) Transmitted light microscopy image of embedded 
constructs printed with hASCs in PL bioinks, showing the transparency of the CNC fibrillar matrix enabling real-time optical analysis (scale bar 250 µm). 
C) SEM image from the cross-section of the interface between PL embedded within the fibrillar matrix of CNC (scale bar 500 nm). D) 3D reconstructions 
of CLM images of the heterogonous model of tissue interface, where hASCs were labeled with green or red cell tracker and bioink hydrogels used are 
PL or GelTG, respectively (scale bar: 1 mm). E) Bright-field and CLM tile scan image of heterogeneous circular construct embedded within the CNC 
matrix illustrating cell compartmentalization, along with F) the respective 3D reconstruction of this CLM image (scale bar: 1 mm).
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metal pins interfaced through the gasket walls, the CNC bath 
was fibrillated with Ca2+ and then the system was sealed and 
perfused for a period of one week to allow cell culture. Inter-
estingly, cells showed homogeneous distributions (Movie S3, 
Supporting Information) and started to organize into a tubular 
monolayer (Figure 6B) with an open lumen covering the inner 
surface of the channel (Figure 6C,D). No invasion of cells into 
the fibrillar CNC matrix was noticed, suggesting that the per-
fusable vascular channels were able to maintain their structural 
integrity during cell culture under dynamic conditions Although 
paper-based microfluidic devices have been previously used 
for in vitro modeling of vascular tissues,[53] their fabrication 
and subsequent cell seeding requires several nonintegrated 
steps. In contrast, our approach allowed in situ endothelization 
whilst maintaining the self-standing structural integrity of the 
channel, in a simple and integrated single process.
Next, tumor models were selected as proof-of-concept sce-
narios to test the potential of this biofabrication platform to 
build multicellular OoC. Based on the design principles of 
state-of-the-art cancer models,[82] the proposed tumor-on-a-chip 
aimed to capture some morphological aspects of the cancer 
environment, namely the biochemical and biophysical cues 
deriving from the compartmentalized structure of the can-
cerous mass surrounded by the vascularized stroma. For this 
purpose, permeable chip gaskets were first printed on glass 
slides with a silicone elastomer ink, in which CNCs fluid gel 
Figure 6. A) Schematic of the assembly of 3D bioprinted chips on printed polylactic acid (PLA) supports used for chip sealing and perfusion (left), 
and a photograph of 3D printed chip made of silicone gasket filled with CNC where HUVEC suspended in gelatin where bioprinted, scale bar: 500 µm 
(right). B) 3D reconstruction CLM images of HUVEC cytoskeleton (green) and nuclei (blue) within bioprinted channels where cells organize into a 
tubular monolayer after 2 weeks under constant perfusion (scale bar: 200 µm). C) Magnified projection image of the channel in B, along with 3D 
cross-section view of endothelialized channel showing an open lumen (scale bar: 100 µm). D) Higher magnification image of B showing endothelial 
cell monolayer (scale bar: 25 µm). E) Schematic of the process for printing the tumor-on-a-chip prototype using various bioinks and other materials to 
construct CNC embedded and compartmentalized structures and allow for culture under dynamic conditions. F) Photograph of the printed chip directly 
used for CLM analysis without the need to disassemble. G) CLM tile scan of the printed tumor model with cancer (MCF-7) cells in the inner circle 
and endothelial (EAy.h926) cells in the outer circle, showing actin staining after 7 d of perfusion culture, (scale bar: 1 mm). H) Immunofluorescence 
images of endothelial cells forming cell–cell contact. I) MCF-7 clusters in the tumor-on-a-chip co-culture conditions in comparison with J) its equivalent 
monoculture (H, I, J scale bar: 25 µm). K) Cell cluster size in monoculture and tumor-on-a-chip co-culture. p***< 0.0001, determined by unpaired t-test 
with Welch’s correction. Images are representative of n  =  3 independent experiments, data are means ± SD.
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was introduced for printing the cellular model (Figure 6F–H). 
Breast cancer cells (MCF-7) were bioprinted in the form of an 
inner ring surrounded by an outer ring of endothelial cells (EA.
hy926). Gelatin was used as biocompatible fugitive ink to print 
peripheral channels around the cellular construct for perfusion 
of culture media. After sealing the system, fresh media was cir-
culated for one week. The immunofluorescence images showed 
the development of MCF-7 clusters (Figure 6J) while endothe-
lial cells tend to form extensive cell-to-cell contacts (Figure 6I), 
although well-developed networks were still not evident at this 
time point. Interestingly, the self-clustering of MCF-7 over time 
to form 3D microaggregates has been correlated with improved 
differentiation of these breast cancer cells[83] and is consistent 
with the signaling of angiocrine factors that regulate tumor 
growth in co-culture models.[84–86] The effects of this paracrine 
crosstalk in co-culture were well evident when comparing it 
with equivalent MCF-7 monoculture OoC systems (Figure 6K), 
where the size of formed cell clusters is significantly lower 
(Figure 6L). Although used here as a first proof-of-concept sce-
nario, the results suggest that this OoC might be a promising 
platform for modeling tumor environments and should there-
fore be further explored with more detail in future functional 
studies.
3. Conclusions
The proposed CNC-based platform supports high-resolution 
printing of perfusable microfluidic channels and embedded 
constructs with arbitrary freeform 3D shapes using different 
low viscosity hydrogel bioinks and cell types. The controlled 
self-assembly of CNC after printing induces their fibrillation 
into networks that recreate the characteristic topography of 
native ECMs and allows the easy interstitial diffusion of mac-
romolecules. It enables the direct writing of living constructs in 
the 3D space of a perfusable bioinspired housing material that 
allows diffusion of signaling biomolecules for cell–cell com-
munications, using a simple extrusion 3D bioprinter without 
the need for specific microfabrication processes, equipment, 
or skills. The automated nature of this biofabrication platform 
further provides significant advantages of throughput, repro-
ducibility, and scalability for the manufacturing of miniaturized 
multicellular systems with complex bioinspired 3D architec-
tures. Additionally, the CNC matrix is transparent for real-time 
monitoring and embedded tissues can be easily harvested 
under mild biocompatible conditions by enzymatic digestion 
with cellulase for further offline processing. This unique set of 
properties in a single system has not been reported to date by 
previous support materials used in embedded 3D bioprinting 
and suggests that it can be a promising platform for the auto-
mated biofabrication of in vitro tissue/organ models, a concept 
that we have here preliminarily demonstrated for the manufac-
turing of OoC.
4. Experimental Section
Production and Tuning of CNC Fluid Gel Rheological Properties: The 
colloidal suspension of CNC was produced by acid hydrolysis of 
microcrystalline cellulose (Sigma-Aldrich) according to the previously 
optimized procedure[37] (detailed protocol is described in Supporting 
Information). For the production of the CNC fluid gel support bath, 
an initial 3 wt% CNC colloidal solution was sonicated for 1 min at 
40% of amplitude output and then diluted to make nanoparticles 
suspensions with the desired concentration (1.5–2.5 wt%). For 
optimization of the printing process, crosslinking agent, i.e., calcium 
chloride solutions (Sigma-Aldrich), was added to CNC at varying 
concentrations (1.5 × 10-3, 2.0 × 10-3, 2.5 × 10-3, and 7.5 × 10-3 m) 
to develop the fluid gel. After the addition of calcium chloride, 
the colloidal suspension was sonicated again for 1 min at 40% of 
amplitude output to ensure homogenous mixing. 500 µL of each 
prepared colloidal suspension was transferred to 1.5 mL Eppendorf 
tubes for the inversion test. After 10 minutes at rest, the tubes were 
inverted upside down to visually inspect the change in viscosity of 
the fluid gels formed.
The 2.5 wt% CNC concentration was chosen for further rheological 
evaluation. To measure the viscoelastic properties of the 2.5 wt% CNC 
colloidal suspension (0 and 2.0 × 10-3 m Ca2+) and fibrillar matrix 
(7.5 × 10-3 m Ca2+), 320 µL of each tested gel was poured on a parallel 
plate setup equipped with a geometry of 20 mm diameter and final 
gap of 1 mm between plates, using a Kinexus Pro Rheometer (Malvern 
Instruments, United Kingdom). The temperature was set at 37 °C and 
frequency 1 Hz. Shear viscosity was measured in response to shear 
rate (0.001 to 100 s-1). Strain-dependent oscillatory shear rheology was 
determined at a fixed frequency of 1 Hz and strains between 0.1% and 
200%. The self-healing properties of the CNC gels (2.0 × 10-3 m and 
7.5 × 10-3 m Ca2+) were measured by alternate strain cycles of 1% and 
200% (n = 3 for all rheological measurements).
“Print-then-lock” Embedded Structures into CNC Fibrillar Matrix: For the 
embedded 3D printing experiments, 2.5 wt% CNC colloidal suspension 
with 2.0 × 10-3 m Ca2+ was chosen as a support matrix based on their 
shear-thinning and self-healing rheological properties. This fluid gel 
was first produced according to the aforementioned process and then 
poured into desired support mold or plate to be used for the printing 
process. BioX (Cellink, Sweden) with pneumatic printheads was used 
for 3D (bio)printing experiments.  Computer-aided designs (CAD) were 
created using the free online software TINKERCAD and saved in stl 
(stereolithography) file format. The human femur was downloaded from 
NIH 3D Print Exchange (Model ID 3DPX-000168) while the human right 
kidney was acquired from Bioverse.com, both models were scaled down 
prior to their conversion into G-code.   The stl to G-code conversion 
program PursaSlic3r 2.1 software was then used to slice the models into 
layers and translate the coordinates into commands. Cartridges of 3 mL 
were loaded with (bio)inks and 27G and 30G blunt needles were used as 
nozzles. The prints were performed applying pressures between 3 and 
5 kPa with the printing speed of 5–8 mm s-1 (unless otherwise specified 
for specific ink or print). After 2–3 min postprinting, the support fluid 
gel was converted into a fibrillar matrix by inducing the hierarchical self-
assembly of CNC through the addition of an excess of 7.5 × 10-3 m Ca2+ 
solution on top of the constructs, hardening it into stable hydrogels 
and locking the embedded 3D structures in place. After 30 min, the 
Ca2+ solution was removed and changed by phosphate buffer saline 
(PBS, Sigma-Aldrich), where the embedded prints were maintained 
until further analysis or cell-cultured following the procedures described 
below.
Preparation and Printing in Agarose Slurry: The agarose bath was 
produced by autoclaving 0.5 wt% Agarose (SeaKem, Lonza, USA) 
with 11 × 10-3 m CaCl2 (Sigma-Aldrich) followed by cooling at constant 
magnetic stirring at 700 rpm to form agarose microparticles.[52] Then, 
the solution was poured into the desired mold to be used for embedded 
printing. The desired structures were directly fabricated in the agarose 
support bath following the same printing protocols described above for 
CNC fluid gel.
Preparation of Acellular Inks: The solution of 10 wt% and 5 wt% 
gelatin (type-A, porcine skin, Sigma-Aldrich) were prepared in PBS 
(Sigma-Aldrich) and their pH was adjusted to 7.4 before further use. 
For the preparation of enzymatically crosslinked gelatin 5 wt% ink 
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(GelTG), the colloidal CNC suspension was supplemented with 
2 wt% transglutaminase enzyme (Ajinomoto, Japan).[47] To prepare the 
alginate ink, sodium alginate (Sigma-Aldrich) 2 wt% was dissolved in 
PBS and stirred at room temperature for 48 h. GelMA was synthesized 
following the pre-established protocol[87] by reacting gelatin (type-A, 
porcine skin, Sigma-Aldrich) with methacrylic anhydride (Sigma-
Aldrich). For the preparation of the photocrosslinkable ink, 5 wt% 
GelMA was dissolved in PBS with 0.5% Irgacure 2959 (Sigma-Aldrich). 
Inbuilt 365 nm light module in BioX printer was used for 3 min and at 
a distance of 3 cm from the light module for GelMA photocuring after 
printing. To aid the visualization of printed structures in photographs 
and transmitted light microscopy images during the optimization 
and characterization steps, food color dyes were added into the inks, 
while for confocal laser microscopy (CLM) fluorescein isothiocyanate–
dextran 250 kDa (Sigma-Aldrich) was added into the ink prior to 
printing. Gelatin 5 wt% and pluronic F-127 25 wt% (Sigma-Aldrich) 
were used as sacrificial inks in the printing of perusable constructs, 
depending on the assay.
Diffusional Permeability Assay: To determine the diffusional 
permeability of biomolecules through the CNC fibrillar matrix, hollow 
channels were fabricated using pluronic F-127 as fugitive ink. The printed 
channels were locked by the addition of 7.5 × 10-3 m calcium chloride 
solution and the fugitive ink was purged after liquefaction by placing 
the fabricated structure at 4 °C. Then, aqueous solutions (25 µg mL-1) 
of 4 kDa or 250 kDa dextran-FITC (Sigma-Aldrich, USA) were separately 
injected into the channel, and samples were immediately observed by 
fluorescence microscopy (Axio Observer, Zeiss, Germany). The diffusion 
of the dextran with different molecular sizes over time (up to 60 min) 
was analyzed by quantification of spatial changes in mean fluorescence 
intensity on the acquired images plotted against the distance from the 
center of the channel.
Cell Isolation and Culture: Human adipose stem cells (hASCs) were 
obtained from lipoaspirate samples of the abdominal region after 
informed consent of patients undergoing plastic surgery, under the scope 
of protocols established with Hospital da Prelada (Porto, Portugal) with 
the approval of the Hospital and University of Minho Ethics Committees 
(approval numbers 005/2019 and 014/2019, respectively). hASCs were 
isolated according to the previously optimized protocol.[88,89] Alpha 
modified Eagle medium (alpha-MEM) supplemented with 10 vol% fetal 
bovine serum (FBS, Thermo Fisher Scientific) and 1 vol% penicillin/
streptomycin solution (Sigma-Aldrich) was used to maintain cells in 
culture. hASCs were not used beyond passage 8. Human umbilical vein 
endothelial cells (HUVEC) were obtained from ThermoFisher Scientific 
and maintained in culture using EndoGRO-MV media (Sigma-Aldrich). 
HUVEC were not used beyond passage 6. MCF-7 breast cancer cell 
line was purchased from Sigma-Aldrich and maintained in culture 
using high glucose Dulbecco’s modified Eagle medium (DMEM, 
Gibco) supplemented with 10% FBS (Thermo Fisher Scientific) and 1% 
antibiotic/antimycotic solution (Sigma-Aldrich). The endothelial cell 
line EA.hy926 (ATCC  CRL-2922) was also commercially obtained from 
(ATCC, LGC Standards, UK) and maintained in culture using low glucose 
Dulbecco’s modified Eagle medium (DMEM, Gibco) supplemented 
with 10% FBS (Thermo Fisher Scientific) and 1% antibiotic/antimycotic 
solution (Sigma-Aldrich).
Preparation of Bioinks: Two bioink hydrogels were used for the 
bioprinting of cellular constructs: GelTG and platelet lysate (PL). 
The GelTG bioink was prepared by adding cell suspension to a 
gelatin 10 wt% in PBS (Sigma-Aldrich) and adjusting the final gelatin 
concentration to 5 wt%. For the preparation of PL bioinks, platelet 
concentrates were obtained from healthy human blood donors, 
provided by Serviço de Imuno-Hemoterapia of Centro Hospitalara de 
S. João, EPE (Porto, Portugal) under an approved institutional board 
protocol (ethical commission of CHSJ/FMUP approved at 18/13/2018). 
PL was produced according to the previously established protocol.[50] 
Briefly, the samples of platelet concentrate were pooled from 12 healthy 
human donors and subjected to three freeze-thaw cycles consisting of 
freezing by immersion in liquid nitrogen followed by heating at 37 °C 
in the water bath. The produced PL was aliquoted and stored at -80 °C 
until further use. The frozen aliquots were thawed at 37 °C for 5 min, 
centrifuged at 4000 G for 5 min (Centrifuge 5810 R, Eppendorf) and 
then filtered with a 0.45 µm pore membrane filter prior to being mixed 
with the trypsinized cell pellets, resulting in the final PL bioinks used 
for bioprinting.
Fabrication of Microphysiological Systems Embedded in CNC Matrix: 
hASCs suspended in GelTG or PL hydrogels at a cell density of 6 × 
106 cells mL-1 were used as bioinks for the fabrication of representative 
microphysiological systems with selected 3D configuration following 
the optimized procedures described for printing with acellular inks. 
Both multiwell plates (for tissue plate demonstration) or cell culture 
µ-Dish (Ibidi, Germany) were used as a support platform for the 
prints, depending on the assay. After printing, the fabricated structures 
were locked with 7.5 × 10-3 m calcium chloride solution, kept in a cell 
incubator for 30 min, and then excess calcium chloride solution was 
replaced by culture media. All the constructs printed with GelTG and PL 
bioinks were cultured up to 4 weeks under standard culture condition 
(alpha-MEM with 10% FBS) except the miniatured human femur bone 
biofabricated with PL bioinks, which was maintained in culture using 
alpha-MEM without supplementation of FBS following the xenofree 
culture conditions we have previously proposed.[50] The media was 
changed every alternate day. (n  =  3 for biologically independent 
experiments).
Harvesting of 3D Constructs from the CNC Fibrillar Matrix: Cellulase 
from Trichoderma reesei[68] (Sigma-Aldrich) at a concentration of 23 g L-1 
in PBS or culture media was used for enzymatic hydrolysis of CNC matrix 
and thus harvest the acellular or bioprinted constructs, respectively. 
The enzyme was sterile filtered prior to use for releasing the bioprinted 
construct. After 24 h of incubation at 37 °C, the released structure was 
washed with PBS and processed for further analysis.
Multimaterial Bioprinting of Dynamic OoC Systems: For fabricating 
perfusion chips, outer silicone gaskets were 3D printed on glass 
slides with DOWSIL TORAY SE 1700 (DOW, USA) in a polymer and 
curing agent proportion of 10:1 using BioX (25G plastic conical needle 
as a nozzle, pressure of 120 kPa, printing speed of 20 mm s-1). 
After printing, the silicone gaskets were kept at 100 °C for 4 h for 
curing. The same procedures described in previous sections were 
applied for bioprinting with the different bioinks on CNC fluid gel 
at 5 kPa and 5.0 mm s-1 using 27G blunt needles as a nozzle. For 
fabrication of perfusable vascular channels, HUVECs in gelatin 5 wt% 
solutions dissolved in EndoGRO-MV at a density of 8 × 106 cells per 
mL were used as bioink to print a single channel of 18 mm length 
and 200 µm diameter. After 2–3 min, the structure was locked with 
7.5 × 10-3 m calcium chloride solution, sealed with a glass slide on 
top of the built construction that was afterward fixed on a custom 
support frame 3D printed using poly-lactic acid (PLA,  Mitsubishi 
Chemicals Performance Polymers, USA) in a B2 × 300 3D printer 
(BEEVERYCREATIVE, Portugal), and placed in a cell incubator for 
liquefaction of gelatin. The perfusion chip was flipped every 10 min 
for 30 min to avoid cell sedimentation. After 2 h of incubation, the 
channel was perfused with EndoGRO-MV media by connecting a 
peristaltic pump to metallic connectors (attached to the perfusion 
chip as inlet and outlet for media) with a flow rate of 40 µL min-1. The 
perfusion chip was kept in dynamic culture for a period of 2 weeks 
(see the assembled setup in Figure S6, Supporting Information).
Similar bioprinting procedures were applied for fabricating the tumor-
on-a-chip model. After printing the external gasket and filling it with CNC 
fluid gel, a circular shaped model was fabricated by first printing the 
inner ring with MCF-7 cancer cells at a density of 6 × 106 cells mL-1 in 
PL, and then EA.hy926 endothelial cells suspended in gelatin 5 wt%/PL 
(3:1 v/v) at a density of 8 × 106 cells mL-1 was used as bioink to print 
the in outer cell rings. After printing the cell structures, gelatin 5 wt% 
solution was used as fugitive ink to print an open external channel 
allowing the circulation of culture media in the periphery of the fabricated 
cellular construct. The CNC was then fibrillated, and the bioprinted 
chip was sealed and connected to a peristaltic pump for perfusion, as 
described above. After incubating the chip at 37 °C, the liquefied fugitive 
ink was purged and then the system was kept in dynamic culture over 
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the period of one week at a flow rate of 40 µL min-1. (n  =  3, biologically 
independent experiments).
Fluorescence Stainings: All fluorescent stainings were performed 
on cell constructs embedded within the CNC matrix except for the 
samples in perfused systems. In this case, similar staining protocols 
were followed but instead of adding reagents in static conditions, all the 
reagents were perfused stepwise via a peristaltic pump. Cell viability on 
the bioprinted constructs was assessed by staining cells with Calcein AM 
(Thermo Fisher Scientific) 1:500 dilution in culture media and propidium 
iodide (Thermo Fisher Scientific) 1:1000 dilution in PBS to stain live and 
dead cells, respectively, on days 1, 3, 7, and 14 for hASCs and day 14 for 
HUVECs. To track hASCs within different compartments after printing, 
cells were labeled with CellTracker Deep Red Dye or CellTracker Green 
CMFDA Dye (ThermoFisher Scientific) following the manufacturer’s 
instructions prior to suspending it in the respective bioink hydrogel to 
aid in visualization after bioprinting. For cell cytoskeleton staining and 
immunolabeling, the samples were first washed with PBS three times 
and 4% paraformaldehyde (Thermo Fisher Scientific) was used to fix 
the cells for 30 minutes at room temperature. Then the cell membrane 
was permeabilized with 0.2% Triton X-100 in PBS for 1 h at room 
temperature. Afterward, the samples were blocked in 1% (w/v) BSA 
in PBS for 1 h at room temperature. F-actin fibers were stained with 
phalloidin conjugated with rhodamine (Sigma-Aldrich, 1:200 dilution) in 
PBS, and nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI, 
Sigma-Aldrich, 1:1000 dilution) in PBS. In the tumor-on-chip, endothelial 
cells were immunolabeled with anti-CD31(PECAM-1)-APC antibody 
(Thermo Fisher Scientific, 1:200 dilution) in 1 wt% BSA solution for 1 h 
at room temperature. Then F-actin fibers were stained with phalloidin 
conjugated with fluorescein isothiocyanate (Sigma-Aldrich) and nuclei 
were counterstained with DAPI. Confocal laser microscope TCS SP8 
(Leica Microsystems, Germany) was used for fluorescence imaging 
acquired directly from the constructions embedded in the CNC matrix. 
ImageJ was used to quantify the proliferative density of cells and for the 
characterization of the size distribution of cell aggregates. Proliferative 
density was estimated from corresponding cells’ area occupied in 
selected regions of interest (ROI). The area of cell aggregates was 
manually defined by their outer boundaries. Results are provided as 
mean ± standard deviation (n  =  3, independent experiments).
Scanning Electron Microscopy (SEM) and Transmission Electron 
Microscopy (STEM): The morphology of CNC was analyzed via STEM 
(Auriga Compact, Zeiss). For sample preparation a drop of 0.0015 wt% 
CNC solution was placed on TEM grids (Carbon Type B, 400 M Cu, 
Monocomp). Images were acquired with an acceleration voltage from 
25 to 30 kV. The microstructure of the CNC fibrillar matrix was observed 
by high-resolution SEM (JSM-6010LV, JEOL, Japan). Before analysis, CNC 
hydrogels were critical point dried after solvent exchange from water to 
ethanol with ethanol gradient from 10 to 99.9 vol%, and then ethanol was 
replaced with liquefied CO2 using critical point dryer (Autosamdri-815 
Series-A Tousimis). To expose the inner structure of dried samples, they 
were freeze-fractured after immersion in liquid nitrogen. Before analysis, 
the samples were sputter-coated with platinum (Cressington Scientific 
Instruments). The images were collected with an acceleration voltage 
from 2 to 10 kV. Image analysis was performed using ImageJ software. 
Results are provided as mean ± standard deviation (n  =  3, independent 
experiments).
Statistical Analysis: The statistical analysis was performed in GraphPad 
Prism 6 software. Two-way ANOVA followed by Tukey’s post hoc tests 
was used for the analysis of variance between multiple groups while 
unpaired two-tailed Student’s t-tests with Welch’s correction was used 
for comparisons between two experimental groups. Results are provided 
as mean ± standard deviation of n ≥ 3 independent experiments. Values 
were considered significant when p < 0.05.
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